Loading...

Tilray Brands, Inc.

TLRYNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.36
$-0.02(-6.08%)

Tilray Brands, Inc. (TLRY) Stock Overview

Explore Tilray Brands, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
25.80%
25.80%
Profit Growth
$-1.04
83.02%
EPS Growth
$-1.04
85.90%
Operating Margin
-87.77%
87.24%
ROE
-28.82%
83.02%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
0
Hold
4
Sell
0
Strong Sell
0

Price Targets

Low$2.00
Average$2.25
High$2.50

Company Profile

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.

CEO

Mr. Irwin David Simon

Employees

2,650

Headquarters

265 Talbot Street West, Leamington, ON

Founded

2018

Frequently Asked Questions

;